BioCentury
ARTICLE | Financial News

Teva completes private placement of convertible preferred stock

December 7, 2015 8:00 AM UTC

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date completed: 2015-12-03 Type: Private placement of convertible preferred stock Rais...